NLS Research

Uncategorized - October 10, 2018

Improving the development of biopharmaceuticals in Finland

Researchers of organic chemistry and biotechnology from the University of Turku are creating new medical technologies in an Ecosystem coordinated by Orion Corporation. ​Together with selected university research groups and other companies, Orion Corporation has assembled a New Modalities Ecosystem supported by funding from Business Finland. One goal of the Ecosystem is to improve the […]

Uncategorized - October 10, 2018

New results about immunotherapy in hereditary melanoma

Researchers at Karolinska Institutet have examined how effective immunological checkpoint therapy is for individuals with inherited CDKN2A mutation and metastatic melanoma. In recent years, new immunological treatments have appeared that many melanoma patients respond well to. These, so called immune checkpoint inhibitors treat cancer by inhibiting brake mechanisms in the immune system, a discovery by […]

Uncategorized - September 12, 2018

Discovery of new neurons in the inner ear

Researchers at Karolinska Institutet have identified four types of neurons in the peripheral auditory system, three of which are new to science, they report Previously, most of the ear’s nerve cells were considered to be of two types: type 1 and type 2 neurons, type 1 transmitting most of the auditory information. The new study […]

Uncategorized - September 6, 2018

New genetic marker could help diagnose prostate cancer

Scientists from the University of Turku have discovered a link between certain genetic mutations, the aggressiveness of prostate cancer, risk of developing the disease and poorer survival rates of patients. The gene, called ANO7, could play a vital role in improving diagnosis of prostate cancer patients, reports the university. Genetic mutations, such as those revealed […]

Uncategorized - September 4, 2018

Mechanism behind multiple sclerosis risk identified

Researchers at Karolinska Institutet have discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. Already over 40 years ago it was discovered that genetic variation in the so-called HLA region is the strongest risk factor for developing disease. HLA encodes molecules that are involved […]

Uncategorized - August 31, 2018

Lorelei Lingard is awarded the Karolinska Institutet Prize for Research in Medical Education

Professor Lorelei Lingard’s research has contributed significantly to our understanding of how healthcare professionals interact and communicate with each other, which has led to new clinical practices and increased patient safety. Professor Lingard, Professor in the Department of Medicine at the Schulich School of Medicine & Dentistry and cross-appointed in the Faculty of Education at […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.